Cerba HealthCare Changes Its Governance and Appoints Emmanuel Ligner Group Chief Executive Officer
Cerba HealthCare, a leading player in medical diagnostics, announces the appointment of Emmanuel Ligner as Chief Executive Officer of the Group. The Group has also strengthened its Supervisory Board with the appointment of Paul Navarre as Chairman and the appointments of Dr. Nuala Murphy and Benoît Ribadeau-Dumas. Their international track records and deep healthcare expertise will support the Group’s expansion in Europe, Africa and North America in clinical pathology for clinical trials, routine and specialty clinical pathology. Cerba HealthCare aims to remain at the forefront of medical innovation to help develop new treatments and improve patient health.
Emmanuel Ligner, Group Chief Executive Officer, said: « Cerba HealthCare is a leading company in the field of medical diagnostics as evidenced by the Group’s growth and the importance it has placed on innovation since its very inception. I am honored to join Cerba HealthCare at this key moment in its history where the expertise of the Group -ranging from routine clinical pathology to clinical pathology for assays- makes it possible to meet the challenges of the personalized medicine of tomorrow. I look forward to joining the management team and meeting with the employees. Together, we will build the next chapter of Cerba HealthCare. »
Paul Navarre, Chairman of the Supervisory Board, adds: « I am very pleased to join the Supervisory Board of Cerba HealthCare, which will invest all its energy and skills into the implementation of our international deployment strategy and the completion of the transformation plan already underway. With Emmanuel’s appointment, the Group is in an excellent position to carry out its growth strategy, powered by its ability to innovate and consolidate its positions across businesses and geographic markets. »
Jérôme Thill, Senior Advisor and former Chief Executive Officer of the Group, adds: « As I step down as Chief Executive Officer, I would like to thank all of Cerba HealthCare’s teams and partners. I wish Emmanuel Ligner and the whole team every success in their new roles.»
Emmanuel Ligner will join Cerba HealthCare on March 1st, 2024. Until then, Paul Navarre will act as the Group’s CEO, with the support of Jérôme Thill, as Senior Advisor, and of Philippe Buhl, as Managing Director.
####
Emmanuel Ligner has had a distinguished career in the healthcare sector. As Chairman and CEO of Cytiva (formerly GE HealthCare Life Sciences) since 2017, he has accelerated the growth trajectory of the group, which doubled sales in recent years. Before taking the helm at Cytiva, Emmanuel held a number of key positions in North America, Europe, the Middle East and Africa. Emmanuel began his career in the late 90s in Japan with Otsuka Pharmaceutical before joining Abbott.
Paul Navarre spent 30 years in management positions at Procter & Gamble, Allergan (President) and Ferring Inc (CEO). He is currently a member of the board of directors of several companies around the world (LEO Pharma, HTL, Hallura) and advises private equity funds.
Dr. Nuala Murphy, a neuroscientist by training, has held senior international positions in the pharmaceutical industry, most recently as President of Development and Commercialization at ICON Plc. In addition to joining the Supervisory Board of Cerba HealthCare, Nuala will take on the role of Executive Chair of Cerba Research.
Benoît Ribadeau-Dumas spent 15 years in senior management positions in the industry sector (Thales, CGG, Zodiac Aerospace), before becoming Chief of Staff to French Prime Minister Edouard Philippe from 2017 to 2020. Benoît is now Managing Director at Exor and a member of various boards, including Stellantis, Iveco, Institut Mérieux and Galileo Global Education.
####
About Cerba HealthCare
Cerba HealthCare, a leading global player in medical diagnostics, aims to support the evolution of health systems towards more prevention. It draws on more than 50 years of expertise in clinical pathology to better assess the risk of diseases development, detect and diagnose diseases earlier, and optimize the effectiveness of personalized medicine.
Every day, on five continents, the Group's 15,000 employees sustain the transformation of medicine, driven by one deep conviction: to advance diagnosis is to advance health.
Cerba HealthCare, enlightening health.
Additional information is available at www.cerbahealthcare.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231109943506/en/
Contact information
Press contact:
Cerba HealthCare
Emmanuelle Saby
+33 6 09 10 76 10
emmanuelle.saby@cerbahealthcare.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation
Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release
Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private
Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding
Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release
V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust
Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo